1. Home
  2. FEMY vs AERT Comparison

FEMY vs AERT Comparison

Compare FEMY & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • AERT
  • Stock Information
  • Founded
  • FEMY 2004
  • AERT 2012
  • Country
  • FEMY United States
  • AERT Singapore
  • Employees
  • FEMY N/A
  • AERT N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • AERT Professional Services
  • Sector
  • FEMY Health Care
  • AERT Consumer Discretionary
  • Exchange
  • FEMY Nasdaq
  • AERT Nasdaq
  • Market Cap
  • FEMY 30.2M
  • AERT 26.8M
  • IPO Year
  • FEMY 2021
  • AERT N/A
  • Fundamental
  • Price
  • FEMY $0.63
  • AERT $0.58
  • Analyst Decision
  • FEMY Strong Buy
  • AERT
  • Analyst Count
  • FEMY 3
  • AERT 0
  • Target Price
  • FEMY $7.33
  • AERT N/A
  • AVG Volume (30 Days)
  • FEMY 13.5M
  • AERT 312.6K
  • Earning Date
  • FEMY 11-11-2025
  • AERT 11-18-2025
  • Dividend Yield
  • FEMY N/A
  • AERT N/A
  • EPS Growth
  • FEMY N/A
  • AERT N/A
  • EPS
  • FEMY N/A
  • AERT N/A
  • Revenue
  • FEMY $1,887,016.00
  • AERT $68,861,000.00
  • Revenue This Year
  • FEMY $103.55
  • AERT N/A
  • Revenue Next Year
  • FEMY $148.13
  • AERT N/A
  • P/E Ratio
  • FEMY N/A
  • AERT N/A
  • Revenue Growth
  • FEMY 98.61
  • AERT N/A
  • 52 Week Low
  • FEMY $0.31
  • AERT $0.46
  • 52 Week High
  • FEMY $1.80
  • AERT $2.67
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 53.65
  • AERT 38.16
  • Support Level
  • FEMY $0.52
  • AERT $0.55
  • Resistance Level
  • FEMY $0.90
  • AERT $0.74
  • Average True Range (ATR)
  • FEMY 0.13
  • AERT 0.04
  • MACD
  • FEMY 0.01
  • AERT -0.01
  • Stochastic Oscillator
  • FEMY 43.95
  • AERT 8.17

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: